Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk-Jan Eikema

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Statistical Methods in Medical Research|March 8, 2022
Benchmarking survival outcomes: A funnel plot for survival dataHein Putter, Dirk-Jan Eikema, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation|February 21, 2024
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparisonDietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, et al.
Transplantation and Cellular Therapy|January 12, 2022
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow TransplantationLoredana Ruggeri, Dirk-Jan Eikema, Attilio Bondanza, et al.
Haematologica|October 5, 2019
Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow TransplantationAndré Tichelli, Régis Peffault de Latour, Jakob Passweg, et al.
American Journal of Hematology|September 23, 2021
Upfront unrelated donor hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: A retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow TransplantationAudrey Françoise Petit, Austin G Kulasekararaj, Dirk-Jan Eikema, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2018
Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case seriesMirjam E Belderbos, Andrew R Gennery, Christopher C Dvorak, et al.
Bone Marrow Transplantation|April 19, 2018
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWPRaffaella Greco, Fabio Ciceri, Maddalena Noviello, et al.
Haematologica|June 24, 2021
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file studyHildegard T Greinix, Dirk-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|December 12, 2018
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted settingAttilio Bondanza, Loredana Ruggeri, Maddalena Noviello, et al.
American Journal of Hematology|June 28, 2026
Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell TransplantationXavier Poiré, Dirk-Jan Eikema, Linda Koster, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Statistical Methods in Medical Research|March 8, 2022
Benchmarking survival outcomes: A funnel plot for survival dataHein Putter, Dirk-Jan Eikema, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation|February 21, 2024
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparisonDietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, et al.
Transplantation and Cellular Therapy|January 12, 2022
Mother Donors Improve Outcomes after HLA Haploidentical Transplantation: A Study by the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow TransplantationLoredana Ruggeri, Dirk-Jan Eikema, Attilio Bondanza, et al.
Haematologica|October 5, 2019
Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow TransplantationAndré Tichelli, Régis Peffault de Latour, Jakob Passweg, et al.
American Journal of Hematology|September 23, 2021
Upfront unrelated donor hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: A retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow TransplantationAudrey Françoise Petit, Austin G Kulasekararaj, Dirk-Jan Eikema, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2018
Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case seriesMirjam E Belderbos, Andrew R Gennery, Christopher C Dvorak, et al.
Bone Marrow Transplantation|April 19, 2018
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWPRaffaella Greco, Fabio Ciceri, Maddalena Noviello, et al.
Haematologica|June 24, 2021
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file studyHildegard T Greinix, Dirk-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|December 12, 2018
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted settingAttilio Bondanza, Loredana Ruggeri, Maddalena Noviello, et al.
American Journal of Hematology|June 28, 2026
Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell TransplantationXavier Poiré, Dirk-Jan Eikema, Linda Koster, et al.
Pageof 4